Standout Papers

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer 2009 2026 2014 2020 979
  1. Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer (2009)
    Jolien Tol, Miriam Koopman et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 14 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Early detection of cancer
2022 StandoutScience
1 intermediate paper

Works of Jolien Tol being referenced

Current issues in the targeted therapy of advanced colorectal cancer.
2010
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
2009 Standout

Author Peers

Author Last Decade Papers Cites
Jolien Tol 1672 729 418 524 42 2.2k
David J. Mauro 1577 747 374 455 26 2.0k
Jin Li 1540 998 358 492 53 2.2k
C. J. Rodenburg 1906 769 364 456 37 2.7k
Katia Bencardino 1734 784 576 580 76 2.3k
J. L. Misset 2110 1016 556 427 63 2.9k
Alessio Amatu 1456 802 599 581 79 2.3k
Jean-Luc Canon 2269 1040 422 309 31 2.7k
Harm Sinnige 1595 557 222 530 29 2.1k
Wendy De Roock 2284 1093 554 647 30 2.8k
Cristiana Lupi 1628 611 363 694 34 2.7k

All Works

Loading papers...

Rankless by CCL
2026